NGRA – Next Generation Risk Assessment
Web Seminar in cooperation with Cosmetics Europe – bookable at any time
Seminar fee: 250 EUR + VAT
Consumer safety is a prerequisite for any cosmetic product. Worldwide, there is an ever-increasing desire to bring safe products to market without animal testing, which requires a new approach to consumer safety. ‘Next Generation Risk Assessment’ (NGRA), defined as an exposure-led, hypothesis driven risk assessment approach that integrates in silico, in chemico and in vitro approaches, provides such an opportunity. This web seminar provides an introduction into the principles and tools of NGRA by case studies and specific approaches for selected endpoints.
Safety assessors evaluate safety of finished cosmetic products taking into account safety information on raw materials. Exhaustive testing of ingredients included in cosmetics as well as continuous improvement of testing and assessment capabilities are therefore key for comprehensive and reliable safety assessment.
The Next Generation Risk Assessment (NGRA) Seminar provides an introduction into a new way of thinking about safety, novel approaches and methodologies that do not use animal data. It offers a true sneak peek into the future of safety evaluations.
The Next Generation Risk Assessment (NGRA) Seminar is a collaboration between IKW/DGK and Cosmetics Europe to help safety assessors better understand the basis of safety evaluation.
Cosmetics Europe has a long-standing experience in the development and evaluation of alternatives to animal testing, among others within such projects as SEURAT-1 and LRSS. IKW/DGK for over 20 years have been conducting reputable trainings for safety assessors well-acknowledged in many countries all over the world.
The Next Generation Risk Assessment (NGRA) Seminar is a unique effort of these organisations to team up and share their knowledge and experience with those who would like to take their safety assessor skills a step further.
|1||Introduction||Dr. Rob Taalman, Cosmetics Europe|
|2||Next Generation Risk Assessment (NGRA): Principles and tools||Dr. Horst Wenck, Beiersdorf|
|3||NGRA in systemic toxicity: Case study of phenoxyethanol||Dr. Gladys Ouédraogo, L’Oréal|
|4||Defined approach for skin sensitization||Dr. Petra Kern, P&G|
|5||Safety assessment of cosmetic ingredients by industry without animal testing||Dr. Carsten Goebel, Coty|